Immunotherapy in allergy and cellular tests

References

• Calderón MA, Casale TB, Togias A, Bousquet J, Durham SR, Demoly P. Allergen-specific immunotherapy for respiratory allergies: from meta-analysis to registration and beyond. J Allergy Clin Immunol 2011; 127:30 - 8; http://dx.doi.org/10.1016/j.jaci.2010.08.024; PMID: 20965551
   PubMed Web of Science ®Google Scholar
• Calderón MA, Boyle RJ, Penagos M, Sheikh A. Immunotherapy: The meta-analyses. What have we Learned?. Immunol Allergy Clin North Am 2011; b 31:159 - 73, vii; http://dx.doi.org/10.1016/j.iac.2011.02.002; PMID: 21530812
   PubMed Web of Science ®Google Scholar
• Wallner M, Pichler U, Ferreira F. Recombinant allergens for pollen immunotherapy. Immunotherapy 2013; 5:1323 - 38; http://dx.doi.org/10.2217/imt.13.114; PMID: 24283843
   PubMed Web of Science ®Google Scholar
• Valenta R, Linhart B, Swoboda I, Niederberger V. Recombinant allergens for allergen-specific immunotherapy: 10 years anniversary of immunotherapy with recombinant allergens. Allergy 2011; 66:775 - 83; http://dx.doi.org/10.1111/j.1398-9995.2011.02565.x; PMID: 21352238
   PubMed Web of Science ®Google Scholar
• Valenta R, Campana R, Marth K, van Hage M. Allergen-specific immunotherapy: from therapeutic vaccines to prophylactic approaches. J Intern Med 2012; 272:144 - 57; http://dx.doi.org/10.1111/j.1365-2796.2012.02556.x; PMID: 22640224
   PubMed Web of Science ®Google Scholar
• Malling HJ. Comparison of the clinical efficacy and safety of subcutaneous and sublingual immunotherapy: methodological approaches and experimental results. Curr Opin Allergy Clin Immunol 2004; 4:539 - 42; http://dx.doi.org/10.1097/00130832-200412000-00011; PMID: 15640696
   PubMed Web of Science ®Google Scholar
• Hui Y, Li L, Qian J, Guo Y, Zhang X, Zhang X. Efficacy analysis of three-year subcutaneous SQ-standardized specific immunotherapy in house dust mite-allergic children with asthma. Exp Ther Med 2014; 7:630 - 4; PMID: 24520258
   PubMed Web of Science ®Google Scholar
• Maloney J, Bernstein DI, Nelson H, Creticos P, Hébert J, Noonan M, Skoner D, Zhou Y, Kaur A, Nolte H. Efficacy and safety of grass sublingual immunotherapy tablet, MK-7243: a large randomized controlled trial. Ann Allergy Asthma Immunol 2014; 112:146 - , e2; http://dx.doi.org/10.1016/j.anai.2013.11.018; PMID: 24468255
   PubMed Web of Science ®Google Scholar
• Chen J, Xiang J, Wang Y, Shi Q, Tan H, Kong W. [Health economics analysis of specific immunotherapy in allergic rhinitis accompanied with asthma]. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2013; 27:925 - 8; PMID: 24367833
   PubMedGoogle Scholar
• Baena-Cagnani CE, Larenas-Linnemann D, Teijeiro A, Canonica GW, Passalacqua G. Will sublingual immunotherapy offer benefit for asthma?. Curr Allergy Asthma Rep 2013; 13:571 - 9; http://dx.doi.org/10.1007/s11882-013-0385-5; PMID: 24022465
   PubMed Web of Science ®Google Scholar
• Martín Muñoz MF. [Efficacy of immunotherapy in the treatment of asthma]. Allergol Immunopathol (Madr) 2004; 32:133 - 41; PMID: 15120030
   PubMedGoogle Scholar
• Bousquet J, Lockey R, Malling HJ. Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper. J Allergy Clin Immunol 1998; 102:558 - 62; http://dx.doi.org/10.1016/S0091-6749(98)70271-4; PMID: 9802362
   PubMed Web of Science ®Google Scholar
• Calderón MA, Casale T, Cox L, Akdis CA, Burks AW, Nelson HS, Jutel M, Demoly P. Allergen immunotherapy: a new semantic framework from the European Academy of Allergy and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL consensus report. Allergy 2013; 68:825 - 8; http://dx.doi.org/10.1111/all.12180; PMID: 24010140
   PubMed Web of Science ®Google Scholar
• Makatsori M, Pfaar O, Lleonart R, Calderon MA. Recombinant allergen immunotherapy: clinical evidence of efficacy--a review. Curr Allergy Asthma Rep 2013; 13:371 - 80; http://dx.doi.org/10.1007/s11882-013-0359-7; PMID: 23740287
   PubMed Web of Science ®Google Scholar
• Larenas-Linnemann D, Blaiss M, Van Bever HP, Compalati E, Baena-Cagnani CE. Pediatric sublingual immunotherapy efficacy: evidence analysis, 2009-2012. Ann Allergy Asthma Immunol 2013; 110:402 - , e9; http://dx.doi.org/10.1016/j.anai.2013.02.017; PMID: 23706708
   PubMed Web of Science ®Google Scholar
• Compalati E, Braido F, Walter Canonica G. Sublingual immunotherapy: recent advances. Allergol Int 2013; 62:415 - 23; http://dx.doi.org/10.2332/allergolint.13-RAI-0627; PMID: 24280671
   PubMed Web of Science ®Google Scholar
• Dranitsaris G, Ellis AK. Sublingual or subcutaneous immunotherapy for seasonal allergic rhinitis: an indirect analysis of efficacy, safety and cost. J Eval Clin Pract 2014; Forthcoming http://dx.doi.org/10.1111/jep.12112; PMID: 24444390
   PubMed Web of Science ®Google Scholar
• Dretzke J, Meadows A, Novielli N, Huissoon A, Fry-Smith A, Meads C. Subcutaneous and sublingual immunotherapy for seasonal allergic rhinitis: a systematic review and indirect comparison. J Allergy Clin Immunol 2013; 131:1361 - 6; http://dx.doi.org/10.1016/j.jaci.2013.02.013; PMID: 23557834
   PubMed Web of Science ®Google Scholar
• Wang J, Sampson HA. Oral and sublingual immunotherapy for food allergy. Asian Pac J Allergy Immunol 2013; 31:198 - 209; PMID: 24053702
   PubMed Web of Science ®Google Scholar
• Calabria CW. Accelerated immunotherapy schedules. Curr Allergy Asthma Rep 2013; 13:389 - 98; http://dx.doi.org/10.1007/s11882-013-0356-x; PMID: 23728613
   PubMed Web of Science ®Google Scholar
• Esch RE, Plunkett GA. Immunotherapy preparation guidelines, rules, and regulation. Curr Allergy Asthma Rep 2013; 13:406 - 13; http://dx.doi.org/10.1007/s11882-013-0358-8; PMID: 23722699
   PubMed Web of Science ®Google Scholar
• MacGlashan DW Jr.. Basophil activation testing. J Allergy Clin Immunol 2013; 132:777 - 87; http://dx.doi.org/10.1016/j.jaci.2013.06.038; PMID: 23958648
   PubMed Web of Science ®Google Scholar
• Chirumbolo S. Basophil activation test to optimize the diagnosis of adverse effects following immunization to vaccines. Iran J Allergy Asthma Immunol 2013; 12:196 - 202; PMID: 23893802
   PubMed Web of Science ®Google Scholar
• Wisniewski J, Agrawal R, Woodfolk JA. Mechanisms of tolerance induction in allergic disease: integrating current and emerging concepts. Clin Exp Allergy 2013; 43:164 - 76; http://dx.doi.org/10.1111/cea.12016; PMID: 23331558
   PubMed Web of Science ®Google Scholar
• de Weck AL, Sanz ML, Gamboa PM, Aberer W, Bienvenu J, Blanca M, Demoly P, Ebo DG, Mayorga L, Monneret G, et al. Diagnostic tests based on human basophils: more potentials and perspectives than pitfalls. Int Arch Allergy Immunol 2008; 146:177 - 89; http://dx.doi.org/10.1159/000115885; PMID: 18268385
   PubMed Web of Science ®Google Scholar
• Erdmann SM, Sachs B, Kwiecien R, Moll-Slodowy S, Sauer I, Merk HF. The basophil activation test in wasp venom allergy: sensitivity, specificity and monitoring specific immunotherapy. Allergy 2004; 59:1102 - 9; http://dx.doi.org/10.1111/j.1398-9995.2004.00624.x; PMID: 15355470
   PubMed Web of Science ®Google Scholar
• Ebo DG, Hagendorens MM, Schuerwegh AJ, Beirens LM, Bridts CH, De Clerck LS, Stevens WJ. Flow-assisted quantification of in vitro activated basophils in the diagnosis of wasp venom allergy and follow-up of wasp venom immunotherapy. Cytometry B Clin Cytom 2007; 72:196 - 203; http://dx.doi.org/10.1002/cyto.b.20142; PMID: 17111386
   PubMed Web of Science ®Google Scholar
• Kucera P, Cvackova M, Hulikova K, Juzova O, Pachl J. Basophil activation can predict clinical sensitivity in patients after venom immunotherapy. J Investig Allergol Clin Immunol 2010; 20:110 - 6; PMID: 20461965
   PubMed Web of Science ®Google Scholar
• Czarnobilska E, Gregorius A, Porebski G, Spiewak R, Sacha M. [The benefits of using basophil activation test as a diagnostic tool prior to specific immunotherapy with inhalant allergens]. Przegl Lek 2012; 69:1249 - 53; PMID: 23750433
   PubMedGoogle Scholar
• Žitnik SE, Vesel T, Avčin T, Šilar M, Košnik M, Korošec P. Monitoring honeybee venom immunotherapy in children with the basophil activation test. Pediatr Allergy Immunol 2012; 23:166 - 72; http://dx.doi.org/10.1111/j.1399-3038.2011.01233.x; PMID: 22136583
   PubMed Web of Science ®Google Scholar
• Chirumbolo S, Zanoni G, Ortolani R, Vella A. In vitro Biphasic Effect of Honey Bee Venom on Basophils from Screened Healthy Blood Donors. Allergy Asthma Immunol Res 2011; 3:58 - 61; http://dx.doi.org/10.4168/aair.2011.3.1.58; PMID: 21217927
   PubMed Web of Science ®Google Scholar
• Przybilla B, Ruëff F. Hymenoptera venom allergy. J Dtsch Dermatol Ges 2010; 8:114 - 27, quiz 128-30; http://dx.doi.org/10.1111/j.1610-0387.2009.07125_supp.x; PMID: 19751222
   PubMed Web of Science ®Google Scholar
• Oka T, Rios EJ, Tsai M, Kalesnikoff J, Galli SJ. Rapid desensitization induces internalization of antigen-specific IgE on mouse mast cells. J Allergy Clin Immunol 2013; 132:922 - , e1-16; http://dx.doi.org/10.1016/j.jaci.2013.05.004; PMID: 23810240
   PubMed Web of Science ®Google Scholar
• Sancho-Serra MdelC, Simarro M, Castells M. Rapid IgE desensitization is antigen specific and impairs early and late mast cell responses targeting FcεRI internalization. Eur J Immunol 2011; 41:1004 - 13; http://dx.doi.org/10.1002/eji.201040810; PMID: 21360700
   PubMed Web of Science ®Google Scholar
• Khodoun MV, Kucuk ZY, Strait RT, Krishnamurthy D, Janek K, Lewkowich I, Morris SC, Finkelman FD. Rapid polyclonal desensitization with antibodies to IgE and FcεRIα. J Allergy Clin Immunol 2013; 131:1555 - 64; http://dx.doi.org/10.1016/j.jaci.2013.02.043; PMID: 23632296
   PubMed Web of Science ®Google Scholar
• Sanz ML, Sánchez G, Gamboa PM, Vila L, Uasuf C, Chazot M, Diéguez I, De Weck AL. Allergen-induced basophil activation: CD63 cell expression detected by flow cytometry in patients allergic to Dermatophagoides pteronyssinus and Lolium perenne. Clin Exp Allergy 2001; 31:1007 - 13; http://dx.doi.org/10.1046/j.1365-2222.2001.01122.x; PMID: 11467990
   PubMed Web of Science ®Google Scholar
• Chirumbolo S. Use of basophil activation test in the investigation of adverse effects to vaccines. Hum Vaccin 2011; 7:878 - 80; http://dx.doi.org/10.4161/hv.7.8.16272; PMID: 21785282
   PubMed Web of Science ®Google Scholar
• Chirumbolo S. Low maintenance dose in honeybee venom immunotherapy and basophil-based tests. Pediatr Allergy Immunol 2011; b 22:644 - 5; http://dx.doi.org/10.1111/j.1399-3038.2011.01168.x; PMID: 21919936
   PubMed Web of Science ®Google Scholar
• Headley A, Katelaris C, Adelstein S. Assessing basophil function. Pathology 2014; 46:Suppl 1 S39; http://dx.doi.org/10.1097/01.PAT.0000443487.35411.87
   Google Scholar
• McGowan EC, Saini S. Update on the performance and application of basophil activation tests. Curr Allergy Asthma Rep 2013; 13:101 - 9; http://dx.doi.org/10.1007/s11882-012-0324-x; PMID: 23188565
   PubMed Web of Science ®Google Scholar
• Macglashan DW Jr., Saini SS. Omalizumab increases the intrinsic sensitivity of human basophils to IgE-mediated stimulation. J Allergy Clin Immunol 2013; 132:906 - , e1-4; http://dx.doi.org/10.1016/j.jaci.2013.04.056; PMID: 23791510
   PubMed Web of Science ®Google Scholar
• Demeule B, Shire SJ, Liu J. A therapeutic antibody and its antigen form different complexes in serum than in phosphate-buffered saline: a study by analytical ultracentrifugation. Anal Biochem 2009; 388:279 - 87; http://dx.doi.org/10.1016/j.ab.2009.03.012; PMID: 19289095
   PubMed Web of Science ®Google Scholar
• Hsu CL, Shiung YY, Lin BL, Chang HY, Chang TW. Accumulated immune complexes of IgE and omalizumab trap allergens in an in vitro model. Int Immunopharmacol 2010; 10:533 - 9; http://dx.doi.org/10.1016/j.intimp.2010.02.001; PMID: 20139035
   PubMed Web of Science ®Google Scholar
• Buhl R. Anti-IgE antibodies for the treatment of asthma. Curr Opin Pulm Med 2005; 11:27 - 34; PMID: 15591885
   PubMed Web of Science ®Google Scholar
• Pfaar O, Klimek L. [Application of humanized Anti-IgE antibodies (omalizumab). A new principle in the treatment of allergic diseases in ENT medicine]. HNO 2007; 55:981 - 90, quiz 991-2; http://dx.doi.org/10.1007/s00106-007-1627-4; PMID: 17992493
   PubMed Web of Science ®Google Scholar
• Chirumbolo S, Olivieri M. Increase in human basophils IgE-mediated stimulation by omalizumab: A role for membrane FcγRs?. J Allergy Clin Immunol 2014; Forthcoming http://dx.doi.org/10.1016/j.jaci.2013.12.1094; PMID: 24642141
   PubMed Web of Science ®Google Scholar
• Dombrowicz D, Lin S, Flamand V, Brini AT, Koller BH, Kinet JP. Allergy-associated FcRbeta is a molecular amplifier of IgE- and IgG-mediated in vivo responses. Immunity 1998; 8:517 - 29; http://dx.doi.org/10.1016/S1074-7613(00)80556-7; PMID: 9586641
   PubMed Web of Science ®Google Scholar
• Zaidi AK, Saini SS, Macglashan DW Jr.. Regulation of Syk kinase and FcRbeta expression in human basophils during treatment with omalizumab. J Allergy Clin Immunol 2010; 125:902 - , e7; http://dx.doi.org/10.1016/j.jaci.2009.12.996; PMID: 20236696
   PubMed Web of Science ®Google Scholar
• Meknache N, Jönsson F, Laurent J, Guinnepain MT, Daëron M. Human basophils express the glycosylphosphatidylinositol-anchored low-affinity IgG receptor FcgammaRIIIB (CD16B). J Immunol 2009; 182:2542 - 50; http://dx.doi.org/10.4049/jimmunol.0801665; PMID: 19201911
   PubMed Web of Science ®Google Scholar
• Eckman JA, Sterba PM, Kelly D, Alexander V, Liu MC, Bochner BS, Macglashan DW Jr., Saini SS. Effects of omalizumab on basophil and mast cell responses using an intranasal cat allergen challenge. J Allergy Clin Immunol 2010; 125:889 - , e7; http://dx.doi.org/10.1016/j.jaci.2009.09.012; PMID: 19962744
   PubMed Web of Science ®Google Scholar
• Bidad K, Nawijn MC, van Oosterhout AJ, van der Heide S, Elberink JN. Basophil Activation Test in the diagnosis and monitoring of mastocytosis patients with wasp venom allergy. Cytometry B Clin Cytom 2013; •••; http://dx.doi.org/10.1002/cytob.21148; PMID: 24327387
   PubMed Web of Science ®Google Scholar
• Korošec P, Šilar M, Eržen R, Čelesnik N, Bajrović N, Zidarn M, Košnik M. Clinical routine utility of basophil activation testing for diagnosis of hymenoptera-allergic patients with emphasis on individuals with negative venom-specific IgE antibodies. Int Arch Allergy Immunol 2013; 161:363 - 8; http://dx.doi.org/10.1159/000348500; PMID: 23689117
   PubMed Web of Science ®Google Scholar
• Bidad K, Nawijn MC, van Oosterhout AJ, van der Heide S, Oude Elberink JN. Basophil activation test in the diagnosis and monitoring of mastocytosis patients with wasp venom allergy on immunotherapy. Cytometry B Clin Cytom 2014; Forthcoming http://dx.doi.org/10.1002/cyto.b.21148; PMID: 24478037
   PubMed Web of Science ®Google Scholar
• Bonadonna P, Zanotti R, Melioli G, Antonini F, Romano I, Lenzi L, Caruso B, Passalacqua G. The role of basophil activation test in special populations with mastocytosis and reactions to hymenoptera sting. Allergy 2012; 67:962 - 5; http://dx.doi.org/10.1111/j.1398-9995.2012.02849.x; PMID: 22676063
   PubMed Web of Science ®Google Scholar
• Chirumbolo S. State-of-the-art review about basophil research in immunology and allergy: is the time right to treat these cells with the respect they deserve?. Blood Transfus 2012; 10:148 - 64; PMID: 22244003
   PubMed Web of Science ®Google Scholar
• Matsuoka T, Shamji MH, Durham SR. Allergen immunotherapy and tolerance. Allergol Int 2013; 62:403 - 13; http://dx.doi.org/10.2332/allergolint.13-RAI-0650; PMID: 24280670
   PubMed Web of Science ®Google Scholar
• Siracusa MC, Kim BS, Spergel JM, Artis D. Basophils and allergic inflammation. J Allergy Clin Immunol 2013; 132:789 - 801, quiz 788; http://dx.doi.org/10.1016/j.jaci.2013.07.046; PMID: 24075190
   PubMed Web of Science ®Google Scholar
• Fujita H, Meyer N, Akdis M, Akdis CA. Mechanisms of immune tolerance to allergens. Chem Immunol Allergy 2012; 96:30 - 8; http://dx.doi.org/10.1159/000331868; PMID: 22433368
   PubMedGoogle Scholar
• Akdis M, Burgler S, Crameri R, Eiwegger T, Fujita H, Gomez E, Klunker S, Meyer N, O’Mahony L, Palomares O, et al. Interleukins, from 1 to 37, and interferon-γ: receptors, functions, and roles in diseases. J Allergy Clin Immunol 2011; 127:701 - 21, e1-70; http://dx.doi.org/10.1016/j.jaci.2010.11.050; PMID: 21377040
   PubMed Web of Science ®Google Scholar
• Getts DR, McCarthy DP, Miller SD. Exploiting apoptosis for therapeutic tolerance induction. J Immunol 2013; 191:5341 - 6; http://dx.doi.org/10.4049/jimmunol.1302070; PMID: 24244028
   PubMed Web of Science ®Google Scholar
• Soyer OU, Akdis M, Ring J, Behrendt H, Crameri R, Lauener R, Akdis CA. Mechanisms of peripheral tolerance to allergens. Allergy 2013; 68:161 - 70; http://dx.doi.org/10.1111/all.12085; PMID: 23253293
   PubMed Web of Science ®Google Scholar
• Alvaro M, Sancha J, Larramona H, Lucas JM, Mesa M, Tabar AI, Martinez-Cañavate A, Immunotherapy Working Group, Sociedad Española de Inmunología Clínica y Alergia Pediátrica (SEICAP). Allergen-specific immunotherapy: update on immunological mechanisms. Allergol Immunopathol (Madr) 2013; 41:265 - 72; http://dx.doi.org/10.1016/j.aller.2012.07.018; PMID: 23332741
   PubMed Web of Science ®Google Scholar
• Eiwegger T, Gruber S, Szépfalusi Z, Akdis CA. Novel developments in the mechanisms of immune tolerance to allergens. Hum Vaccin Immunother 2012; 8:1485 - 91; http://dx.doi.org/10.4161/hv.20903; PMID: 23095863
   PubMed Web of Science ®Google Scholar
• Kucuksezer UC, Ozdemir C, Akdis M, Akdis CA. Mechanisms of immune tolerance to allergens in children. Korean J Pediatr 2013; 56:505 - 13; http://dx.doi.org/10.3345/kjp.2013.56.12.505; PMID: 24416044
   PubMedGoogle Scholar
• Jutel M, Van de Veen W, Agache I, Azkur KA, Akdis M, Akdis CA. Mechanisms of allergen-specific immunotherapy and novel ways for vaccine development. Allergol Int 2013; 62:425 - 33; http://dx.doi.org/10.2332/allergolint.13-RAI-0608; PMID: 24153333
   PubMed Web of Science ®Google Scholar
• Kepley CL. Antigen-induced reduction in mast cell and basophil functional responses due to reduced Syk protein levels. Int Arch Allergy Immunol 2005; 138:29 - 39; http://dx.doi.org/10.1159/000087355; PMID: 16088210
   PubMed Web of Science ®Google Scholar
• MacGlashan D Jr.. Subthreshold desensitization of human basophils re-capitulates the loss of Syk and FcεRI expression characterized by other methods of desensitization. Clin Exp Allergy 2012; 42:1060 - 70; http://dx.doi.org/10.1111/j.1365-2222.2012.04013.x; PMID: 22702505
   PubMed Web of Science ®Google Scholar
• MacGlashan D Jr., Lichtenstein LM. Studies of antigen binding on human basophils. I. Antigen binding and functional consequences. J Immunol 1983; 130:2330 - 6; PMID: 6187850
   PubMed Web of Science ®Google Scholar
• MacGlashan D Jr., Mogowski M, Lichtenstein LM. Studies of antigen binding on human basophils. II. Continued expression of antigen-specific IgE during antigen-induced desensitization. J Immunol 1983; 130:2337 - 42; PMID: 6187851
   PubMed Web of Science ®Google Scholar
• MacGlashan DW Jr., Dembo M, Goldstein B. Test of a theory relating to the cross-linking of IgE antibody on the surface of human basophils. J Immunol 1985; 135:4129 - 34; PMID: 2415601
   PubMed Web of Science ®Google Scholar
• MacGlashan DW Jr.. Releasability of human basophils: cellular sensitivity and maximal histamine release are independent variables. J Allergy Clin Immunol 1993; 91:605 - 15; http://dx.doi.org/10.1016/0091-6749(93)90266-I; PMID: 7679683
   PubMed Web of Science ®Google Scholar
• MacGlashan D Jr., McKenzie-White J, Chichester K, Bochner BS, Davis FM, Schroeder JT, Lichtenstein LM. In vitro regulation of FcepsilonRIalpha expression on human basophils by IgE antibody. Blood 1998; 91:1633 - 43; PMID: 9473229
   PubMed Web of Science ®Google Scholar
• MacGlashan D Jr., Lavens-Phillips S, Katsushi M. IgE-mediated desensitization in human basophils and mast cells. Front Biosci 1998; 3:d746 - 56; PMID: 9680509
   PubMedGoogle Scholar
• Macglashan D Jr.. IgE and FcepsilonRI regulation. Ann N Y Acad Sci 2005; 1050:73 - 88; http://dx.doi.org/10.1196/annals.1313.009; PMID: 16014522
   PubMed Web of Science ®Google Scholar
• Warner J, MacGlashan D Jr.. Persistence of early crosslink-dependent signal transduction events in human basophils after desensitization. Immunol Lett 1988; 18:129 - 37; http://dx.doi.org/10.1016/0165-2478(88)90053-3; PMID: 2456986
   PubMed Web of Science ®Google Scholar
• MacGlashan DW Jr., Bochner BS, Warner JA. Graded changes in the response of individual human basophils to stimulation: distributional behavior of early activation events. J Leukoc Biol 1994; 55:13 - 23; PMID: 7506746
   PubMed Web of Science ®Google Scholar
• MacGlashan DW Jr.. Graded changes in the response of individual human basophils to stimulation: distributional behavior of events temporally coincident with degranulation. J Leukoc Biol 1995; 58:177 - 88; PMID: 7543919
   PubMed Web of Science ®Google Scholar
• Chirumbolo S. Monitoring of CD63% in basophil activation test and suggested new parameters for allergy diagnosis. Inflamm Res 2012; 61:171 - 6; http://dx.doi.org/10.1007/s00011-011-0416-4; PMID: 22205176
   PubMed Web of Science ®Google Scholar
• Nguyen KL, Gillis S, MacGlashan DW Jr.. A comparative study of releasing and nonreleasing human basophils: nonreleasing basophils lack an early component of the signal transduction pathway that follows IgE cross-linking. J Allergy Clin Immunol 1990; 85:1020 - 9; http://dx.doi.org/10.1016/0091-6749(90)90046-7; PMID: 1693929
   PubMed Web of Science ®Google Scholar
• MacGlashan D Jr., Guo CB. Oscillations in free cytosolic calcium during IgE-mediated stimulation distinguish human basophils from human mast cells. J Immunol 1991; 147:2259 - 69; PMID: 1918962
   PubMed Web of Science ®Google Scholar
• Macglashan D, Miura K. Loss of syk kinase during IgE-mediated stimulation of human basophils. J Allergy Clin Immunol 2004; 114:1317 - 24; http://dx.doi.org/10.1016/j.jaci.2004.08.037; PMID: 15577829
   PubMed Web of Science ®Google Scholar
• MacGlashan D Jr., Vilariño N. Nonspecific desensitization, functional memory, and the characteristics of SHIP phosphorylation following IgE-mediated stimulation of human basophils. J Immunol 2006; 177:1040 - 51; http://dx.doi.org/10.4049/jimmunol.177.2.1040; PMID: 16818760
   PubMed Web of Science ®Google Scholar
• Gendelman SR, Lang DM. Specific immunotherapy in the treatment of atopic dermatitis: a systematic review using the GRADE system. Ann Allergy Asthma Immunol 2013; 111:555 - 61; http://dx.doi.org/10.1016/j.anai.2013.08.020; PMID: 24267368
   PubMed Web of Science ®Google Scholar
• Bae JM, Choi YY, Park CO, Chung KY, Lee KH. Efficacy of allergen-specific immunotherapy for atopic dermatitis: a systematic review and meta-analysis of randomized controlled trials. J Allergy Clin Immunol 2013; 132:110 - 7; http://dx.doi.org/10.1016/j.jaci.2013.02.044; PMID: 23647790
   PubMed Web of Science ®Google Scholar
• Kim JM, Lin SY, Suarez-Cuervo C, Chelladurai Y, Ramanathan M, Segal JB, Erekosima N. Allergen-specific immunotherapy for pediatric asthma and rhinoconjunctivitis: a systematic review. Pediatrics 2013; 131:1155 - 67; http://dx.doi.org/10.1542/peds.2013-0343; PMID: 23650298
   PubMed Web of Science ®Google Scholar
• Lin SY, Erekosima N, Kim JM, Ramanathan M, Suarez-Cuervo C, Chelladurai Y, Ward D, Segal JB. Sublingual immunotherapy for the treatment of allergic rhinoconjunctivitis and asthma: a systematic review. JAMA 2013; 309:1278 - 88; http://dx.doi.org/10.1001/jama.2013.2049; PMID: 23532243
   PubMed Web of Science ®Google Scholar
• Blumberga G, Groes L, Dahl R. SQ-standardized house dust mite immunotherapy as an immunomodulatory treatment in patients with asthma. Allergy 2011; 66:178 - 85; http://dx.doi.org/10.1111/j.1398-9995.2010.02451.x; PMID: 20883456
   PubMed Web of Science ®Google Scholar
• Chen S, Wang L, Liao F, Zeng X, Xing QB, Chen B, Lin XZ. [Efficacy of sublingual immunotherapy with Dermatophagoides farinae drops in preschool and school-age children with allergic asthma and allergic rhinitis]. Zhonghua Er Ke Za Zhi 2013; 51:831 - 5; PMID: 24484557
   PubMedGoogle Scholar
• Wen CJ, Zhu MF, Ren WM, Liu XY, Qian H. [Clinical efficacy and safety of sublingual immunotherapy using standardized Dermatophagoides farinae extract for children with combined allergic rhinitis and asthma syndrome]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2011; 46:393 - 6; PMID: 21781561
   PubMedGoogle Scholar
• Radulovic S, Calderon MA, Wilson D, Durham S. Sublingual immunotherapy for allergic rhinitis. Cochrane Database Syst Rev 2010; CD002893; PMID: 21154351
   PubMed Web of Science ®Google Scholar
• Creticos PS, Esch RE, Couroux P, Gentile D, D'Angelo P, Whitlow B, Alexander M, Coyne TC. Randomized, double-blind, placebo-controlled trial of standardized ragweed sublingual-liquid immunotherapy for allergic rhinoconjunctivitis. J Allergy Clin Immunol 2013; http://dx.doi.org/10.1016/j.jaci.2012.12.1183; PMID: 24332263
   PubMed Web of Science ®Google Scholar
• Nolte H, Hébert J, Berman G, Gawchik S, White M, Kaur A, Liu N, Lumry W, Maloney J. Randomized controlled trial of ragweed allergy immunotherapy tablet efficacy and safety in North American adults. Ann Allergy Asthma Immunol 2013; 110:450 - , e4; http://dx.doi.org/10.1016/j.anai.2013.03.013; PMID: 23706715
   PubMed Web of Science ®Google Scholar
• Mikkelsen S, Bibby BM, Dolberg MK, Dahl R, Hoffmann HJ. Basophil sensitivity through CD63 or CD203c is a functional measure for specific immunotherapy. Clin Mol Allergy 2010; 8:2; http://dx.doi.org/10.1186/1476-7961-8-2; PMID: 20158902
   PubMedGoogle Scholar
• Macglashan DW Jr., Saini SS. Omalizumab increases the intrinsic sensitivity of human basophils to IgE-mediated stimulation. J Allergy Clin Immunol 2013; 132:906 - , e1-4; http://dx.doi.org/10.1016/j.jaci.2013.04.056; PMID: 23791510
   PubMed Web of Science ®Google Scholar
• Francis JN, James LK, Paraskevopoulos G, Wong C, Calderon MA, Durham SR, Till SJ. Grass pollen immunotherapy: IL-10 induction and suppression of late responses precedes IgG4 inhibitory antibody activity. J Allergy Clin Immunol 2008; 121:1120 - 5, e2; http://dx.doi.org/10.1016/j.jaci.2008.01.072; PMID: 18374405
   PubMed Web of Science ®Google Scholar
• Boumiza R, Monneret G, Forissier MF, Savoye J, Gutowski MC, Powell WS, Bienvenu J. Marked improvement of the basophil activation test by detecting CD203c instead of CD63. Clin Exp Allergy 2003; 33:259 - 65; http://dx.doi.org/10.1046/j.1365-2222.2003.01594.x; PMID: 12580920
   PubMed Web of Science ®Google Scholar
• Lasa Luaces EM, Tabar Purroy AI, García Figueroa BE, Anda Apiñaniz M, Sanz Laruga ML, Raulf-Heimsoth M, Barber Hernández D. Component-resolved immunologic modifications, efficacy, and tolerance of latex sublingual immunotherapy in children. Ann Allergy Asthma Immunol 2012; 108:367 - 72; http://dx.doi.org/10.1016/j.anai.2012.03.005; PMID: 22541410
   PubMed Web of Science ®Google Scholar
• Nettis E, Delle Donne P, Di Leo E, Fantini P, Passalacqua G, Bernardini R, Canonica GW, Ferrannini A, Vacca A. Latex immunotherapy: state of the art. Ann Allergy Asthma Immunol 2012; 109:160 - 5; http://dx.doi.org/10.1016/j.anai.2012.07.004; PMID: 22920069
   PubMed Web of Science ®Google Scholar
• Chini L, Monteferrario E, Graziani S, Moschese V. Novel treatments of asthma and allergic diseases. Paediatr Respir Rev 2013; PMID: 24287269
   PubMed Web of Science ®Google Scholar
• Larenas-Linnemann D, Blaiss M, Van Bever HP, Compalati E, Baena-Cagnani CE. Pediatric sublingual immunotherapy efficacy: evidence analysis, 2009-2012. Ann Allergy Asthma Immunol 2013; 110:402 - , e9; http://dx.doi.org/10.1016/j.anai.2013.02.017; PMID: 23706708
   PubMed Web of Science ®Google Scholar
• El-Qutob D, Mencia G, Fernandez-Caldas E. Recent Advances in Immunotherapy for Allergic Diseases. Recent Pat Inflamm Allergy Drug Discov 2013; Forthcoming PMID: 24237114
   PubMedGoogle Scholar
• Wu AY. Immunotherapy - Vaccines for allergic diseases. J Thorac Dis 2012; 4:198 - 202; PMID: 22833826
   PubMed Web of Science ®Google Scholar
• Senna G, Caminati M, Canonica GW. Safety and tolerability of sublingual immunotherapy in clinical trials and real life. Curr Opin Allergy Clin Immunol 2013; 13:656 - 62; http://dx.doi.org/10.1097/ACI.0000000000000007; PMID: 24126613
   PubMed Web of Science ®Google Scholar
• Bahceciler NN, Cobanoglu N. Subcutaneous versus sublingual immunotherapy for allergic rhinitis and/or asthma. Immunotherapy 2011; 3:747 - 56; http://dx.doi.org/10.2217/imt.11.48; PMID: 21668312
   PubMed Web of Science ®Google Scholar
• Marrs T, Anagnostou K, Fitzsimons R, Fox AT. Optimising treatment of allergic rhinitis in children. Practitioner 2013; 257:13 - 8, 2; PMID: 23905284
   PubMedGoogle Scholar
• Manzotti G, Lombardi C. Allergen immunotherapy as a drug: the new deal of grass allergen tablets from clinical trials to current practice. Eur Ann Allergy Clin Immunol 2013; 45:34 - 42; PMID: 23821831
   PubMedGoogle Scholar
• Queirós MG, Silva DA, Siman IL, Ynoue LH, Araújo NS, Pereira FL, Almeida KC, Miranda JS, Pena JD, Cunha-Junior JP, et al. Modulation of mucosal/systemic antibody response after sublingual immunotherapy in mite-allergic children. Pediatr Allergy Immunol 2013; 24:752 - 61; http://dx.doi.org/10.1111/pai.12163; PMID: 24299565
   PubMed Web of Science ®Google Scholar
• Compalati E, Braido F, Canonica GW. An update on allergen immunotherapy and asthma. Curr Opin Pulm Med 2014; 20:109 - 17; http://dx.doi.org/10.1097/MCP.0000000000000016; PMID: 24296688
   PubMed Web of Science ®Google Scholar
• Passalacqua G. Specific immunotherapy in asthma: a comprehensive review. J Asthma 2014; 51:29 - 33; http://dx.doi.org/10.3109/02770903.2013.853082; PMID: 24219841
   PubMed Web of Science ®Google Scholar
• Gendelman SR, Lang DM. Specific immunotherapy in the treatment of atopic dermatitis: a systematic review using the GRADE system. Ann Allergy Asthma Immunol 2013; 111:555 - 61; http://dx.doi.org/10.1016/j.anai.2013.08.020; PMID: 24267368
   PubMed Web of Science ®Google Scholar
• Compalati E, Rogkakou A, Passalacqua G, Canonica GW. Evidences of efficacy of allergen immunotherapy in atopic dermatitis: an updated review. Curr Opin Allergy Clin Immunol 2012; 12:427 - 33; http://dx.doi.org/10.1097/ACI.0b013e328354e540; PMID: 22622475
   PubMed Web of Science ®Google Scholar
• Vieths S, Scheurer S, Ballmer-Weber B. Current understanding of cross-reactivity of food allergens and pollen. Ann N Y Acad Sci 2002; 964:47 - 68; http://dx.doi.org/10.1111/j.1749-6632.2002.tb04132.x; PMID: 12023194
   PubMed Web of Science ®Google Scholar
• Pauli G, Metz-Favre C. [Cross reactions between pollens and vegetable food allergens]. Rev Mal Respir 2013; 30:328 - 37; http://dx.doi.org/10.1016/j.rmr.2012.10.633; PMID: 23664291
   PubMed Web of Science ®Google Scholar
• Leysen J, De Witte L, Sabato V, Faber M, Hagendorens M, Bridts C, De Clerck L, Ebo D. IgE-mediated allergy to pholcodine and cross-reactivity to neuromuscular blocking agents: Lessons from flow cytometry. Cytometry B Clin Cytom 2013; 84:65 - 70; http://dx.doi.org/10.1002/cyto.b.21074; PMID: 23355309
   PubMed Web of Science ®Google Scholar
• Ismail IH, Tang ML. Oral immunotherapy for the treatment of food allergy. Isr Med Assoc J 2012; 14:63 - 9; PMID: 22624447
   PubMed Web of Science ®Google Scholar
• Ojeda P, Ojeda I, Rubio G, Pineda F. Home-based oral immunotherapy protocol with pasteurized egg for children allergic to hen’s egg. Isr Med Assoc J 2012; 14:34 - 9; PMID: 22624440
   PubMed Web of Science ®Google Scholar
• Sánchez-García S, Rodríguez del Río P, Escudero C, García-Fernández C, Ramirez A, Ibáñez MD. Efficacy of oral immunotherapy protocol for specific oral tolerance induction in children with cow’s milk allergy. Isr Med Assoc J 2012; 14:43 - 7; PMID: 22624442
   PubMed Web of Science ®Google Scholar
• Crisafulli G, Caminiti L, Pajno GB. Oral desensitization for immunoglobulin E-mediated milk and egg allergies. Isr Med Assoc J 2012; 14:53 - 6; PMID: 22624445
   PubMed Web of Science ®Google Scholar
• Tammaro A, Narcisi A, Amodeo R, Portaro L, Tabacco F, Cardelli P, Persechino S. CD63 cell expression detected by flow-cytometric determination of basophil activation in allergic patients. Int J Immunopathol Pharmacol 2012; 25:1143 - 7; PMID: 23298505
   PubMed Web of Science ®Google Scholar
• Nurmatov U, Venderbosch I, Devereux G, Simons FE, Sheikh A. Allergen-specific oral immunotherapy for peanut allergy. Cochrane Database Syst Rev 2012; 9:CD009014; PMID: 22972130
   PubMed Web of Science ®Google Scholar
• Varshney P, Jones SM, Scurlock AM, Perry TT, Kemper A, Steele P, Hiegel A, Kamilaris J, Carlisle S, Yue X, et al. A randomized controlled study of peanut oral immunotherapy: clinical desensitization and modulation of the allergic response. J Allergy Clin Immunol 2011; 127:654 - 60; http://dx.doi.org/10.1016/j.jaci.2010.12.1111; PMID: 21377034
   PubMed Web of Science ®Google Scholar
• Burks AW, Jones SM, Wood RA, Fleischer DM, Sicherer SH, Lindblad RW, Stablein D, Henning AK, Vickery BP, Liu AH, et al, Consortium of Food Allergy Research (CoFAR). Oral immunotherapy for treatment of egg allergy in children. N Engl J Med 2012; 367:233 - 43; http://dx.doi.org/10.1056/NEJMoa1200435; PMID: 22808958
   PubMed Web of Science ®Google Scholar
• Narisety SD, Keet CA. Sublingual vs oral immunotherapy for food allergy: identifying the right approach. Drugs 2012; 72:1977 - 89; http://dx.doi.org/10.2165/11640800-000000000-00000; PMID: 23009174
   PubMed Web of Science ®Google Scholar
• Sampson HA. Peanut oral immunotherapy: is it ready for clinical practice?. J Allergy Clin Immunol Pract 2013; 1:15 - 21; http://dx.doi.org/10.1016/j.jaip.2012.10.009; PMID: 24229817
   PubMed Web of Science ®Google Scholar
• Tang ML. Oral immunotherapy for food allergy. Curr Allergy Asthma Rep 2009; 9:43 - 9; http://dx.doi.org/10.1007/s11882-009-0007-4; PMID: 19063824
   PubMed Web of Science ®Google Scholar
• Virkud YV, Vickery BP. Advances in immunotherapy for food allergy. Discov Med 2012; 14:159 - 65; PMID: 23021370
   PubMed Web of Science ®Google Scholar
• Sampson HA. Peanut oral immunotherapy: is it ready for clinical practice?. J Allergy Clin Immunol Pract 2013; 1:15 - 21; http://dx.doi.org/10.1016/j.jaip.2012.10.009; PMID: 24229817
   PubMed Web of Science ®Google Scholar
• Henson M, Burks AW. The future of food allergy therapeutics. Semin Immunopathol 2012; 34:703 - 14; http://dx.doi.org/10.1007/s00281-012-0319-7; PMID: 22735939
   PubMed Web of Science ®Google Scholar
• De Silva D, Geromi M, Panesar SS, Muraro A, Werfel T, Hoffmann-Sommergruber K, Roberts G, Cardona V, Dubois AE, Halken S, et al. the EAACI Food Allergy and Anaphylaxis Group. Acute and long-term management of food allergy: systematic review. Allergy 2013; Forthcoming PMID: 24215577
   PubMed Web of Science ®Google Scholar
• Fleischer DM, Burks AW, Vickery BP, Scurlock AM, Wood RA, Jones SM, Sicherer SH, Liu AH, Stablein D, Henning AK, et al, Consortium of Food Allergy Research (CoFAR). Sublingual immunotherapy for peanut allergy: a randomized, double-blind, placebo-controlled multicenter trial. J Allergy Clin Immunol 2013; 131:119 - , e1-7; http://dx.doi.org/10.1016/j.jaci.2012.11.011; PMID: 23265698
   PubMed Web of Science ®Google Scholar
• Hourihane JO. Recent advances in peanut allergy. Curr Opin Allergy Clin Immunol 2002; 2:227 - 31; http://dx.doi.org/10.1097/00130832-200206000-00012; PMID: 12045419
   PubMed Web of Science ®Google Scholar
• Al-Muhsen S, Clarke AE, Kagan RS. Peanut allergy: an overview. [Review. Erratum in: CMAJ. 2003 Jun 10;168] [12] CMAJ 2003; 168:1279 - 85; PMID: 12743075
   PubMed Web of Science ®Google Scholar
• Yu GP, Weldon B, Neale-May S, Nadeau KC. The safety of peanut oral immunotherapy in peanut-allergic subjects in a single-center trial. Int Arch Allergy Immunol 2012; 159:179 - 82; http://dx.doi.org/10.1159/000336391; PMID: 22678151
   PubMed Web of Science ®Google Scholar
• Kostadinova AI, Willemsen LE, Knippels LM, Garssen J. Immunotherapy - risk/benefit in food allergy. Pediatr Allergy Immunol 2013; 24:633 - 44; PMID: 24112425
   PubMed Web of Science ®Google Scholar
• Mitsias DI, Kalogiros LA, Papadopoulos NG. Conference Scene: novelties in immunotherapy. Immunotherapy 2013; 5:1033 - 7; http://dx.doi.org/10.2217/imt.13.109; PMID: 24088073
   PubMed Web of Science ®Google Scholar
• Staden U, Rolinck-Werninghaus C, Brewe F, Wahn U, Niggemann B, Beyer K. Specific oral tolerance induction in food allergy in children: efficacy and clinical patterns of reaction. Allergy 2007; 62:1261 - 9; http://dx.doi.org/10.1111/j.1398-9995.2007.01501.x; PMID: 17919140
   PubMed Web of Science ®Google Scholar
• Morisset M, Moneret-Vautrin DA, Guenard L, Cuny JM, Frentz P, Hatahet R, Hanss Ch, Beaudouin E, Petit N, Kanny G. Oral desensitization in children with milk and egg allergies obtains recovery in a significant proportion of cases. A randomized study in 60 children with cow’s milk allergy and 90 children with egg allergy. Eur Ann Allergy Clin Immunol 2007; 39:12 - 9; PMID: 17375736
   PubMedGoogle Scholar
• Patriarca G, Nucera E, Pollastrini E, Roncallo C, De Pasquale T, Lombardo C, Pedone C, Gasbarrini G, Buonomo A, Schiavino D. Oral specific desensitization in food-allergic children. Dig Dis Sci 2007; 52:1662 - 72; http://dx.doi.org/10.1007/s10620-006-9245-7; PMID: 17245630
   PubMed Web of Science ®Google Scholar
• Skripak JM, Nash SD, Rowley H, Brereton NH, Oh S, Hamilton RG, Matsui EC, Burks AW, Wood RA. A randomized, double-blind, placebo-controlled study of milk oral immunotherapy for cow’s milk allergy. J Allergy Clin Immunol 2008; 122:1154 - 60; http://dx.doi.org/10.1016/j.jaci.2008.09.030; PMID: 18951617
   PubMed Web of Science ®Google Scholar
• Longo G, Berti I, Burks AW, Krauss B, Barbi E. IgE-mediated food allergy in children. Lancet 2013; 382:1656 - 64; http://dx.doi.org/10.1016/S0140-6736(13)60309-8; PMID: 23845860
   PubMed Web of Science ®Google Scholar
• Boyce JA, Assa’ad A, Burks AW, Jones SM, Sampson HA, Wood RA, Plaut M, Cooper SF, Fenton MJ, Arshad SH, et al, NIAID-Sponsored Expert Panel. Guidelines for the diagnosis and management of food allergy in the United States: report of the NIAID-sponsored expert panel. J Allergy Clin Immunol 2010; 126:Suppl S1 - 58; http://dx.doi.org/10.1016/j.jaci.2010.10.008; PMID: 21134576
   PubMed Web of Science ®Google Scholar
• Burks AW, Jones SM, Boyce JA, Sicherer SH, Wood RA, Assa’ad A, Sampson HA. NIAID-sponsored 2010 guidelines for managing food allergy: applications in the pediatric population. Pediatrics 2011; 128:955 - 65; http://dx.doi.org/10.1542/peds.2011-0539; PMID: 21987705
   PubMed Web of Science ®Google Scholar
• Kukkonen AK, Mäkelä M, Pelkonen A. [Nut allergy - a difficult problem for the clinician]. Duodecim 2013; 129:1263 - 70; PMID: 23847912
   PubMedGoogle Scholar
• Longo G, Barbi E, Berti I, Meneghetti R, Pittalis A, Ronfani L, Ventura A. Specific oral tolerance induction in children with very severe cow’s milk-induced reactions. J Allergy Clin Immunol 2008; 121:343 - 7; http://dx.doi.org/10.1016/j.jaci.2007.10.029; PMID: 18158176
   PubMed Web of Science ®Google Scholar
• Martinolli F, Carraro S, Berardi M, Ferraro V, Baraldi E, Zanconato S. Immunotherapy For Food Allergies In Children. Curr Pharm Des 2013; Forthcoming PMID: 23701567
   PubMed Web of Science ®Google Scholar
• Mansfield LE. Oral immunotherapy for peanut allergy in clinical practice is ready. Allergy Asthma Proc 2013; 34:205 - 9; http://dx.doi.org/10.2500/aap.2013.34.3666; PMID: 23676569
   PubMed Web of Science ®Google Scholar
• Greenhawt MJ. Oral and sublingual peanut immunotherapy is not ready for general use. Allergy Asthma Proc 2013; 34:197 - 204; http://dx.doi.org/10.2500/aap.2013.34.3661; PMID: 23676568
   PubMed Web of Science ®Google Scholar
• Calderón MA, Frankland AW, Demoly P. Allergen immunotherapy and allergic rhinitis: false beliefs. BMC Med 2013; 11:255; http://dx.doi.org/10.1186/1741-7015-11-255; PMID: 24314210
   PubMed Web of Science ®Google Scholar
• Calderon MA, Gerth van Wijk R, Eichler I, Matricardi PM, Varga EM, Kopp MV, Eng P, Niggemann B, Nieto A, Valovirta E, et al, European Academy of Allergy and Clinical Immunology. Perspectives on allergen-specific immunotherapy in childhood: an EAACI position statement. Pediatr Allergy Immunol 2012; 23:300 - 6; http://dx.doi.org/10.1111/j.1399-3038.2012.01313.x; PMID: 22594930
   PubMed Web of Science ®Google Scholar
• Cox L, Compalati E, Kundig T, Larche M. New directions in immunotherapy. Curr Allergy Asthma Rep 2013; 13:178 - 95; http://dx.doi.org/10.1007/s11882-012-0335-7; PMID: 23315329
   PubMed Web of Science ®Google Scholar
• Monteiro RC, Van De Winkel JG. IgA Fc receptors. Annu Rev Immunol 2003; 21:177 - 204; http://dx.doi.org/10.1146/annurev.immunol.21.120601.141011; PMID: 12524384
   PubMed Web of Science ®Google Scholar
• Kanamaru Y, Arcos-Fajardo M, Moura IC, Tsuge T, Cohen H, Essig M, Vrtovsnik F, Loirat C, Peuchmaur M, Beaudoin L, et al. Fc alpha receptor I activation induces leukocyte recruitment and promotes aggravation of glomerulonephritis through the FcR gamma adaptor. Eur J Immunol 2007; 37:1116 - 28; http://dx.doi.org/10.1002/eji.200636826; PMID: 17393381
   PubMed Web of Science ®Google Scholar
• van der Steen LP, Bakema JE, Sesarman A, Florea F, Tuk CW, Kirtschig G, Hage JJ, Sitaru C, van Egmond M. Blocking Fcα receptor I on granulocytes prevents tissue damage induced by IgA autoantibodies. J Immunol 2012; 189:1594 - 601; http://dx.doi.org/10.4049/jimmunol.1101763; PMID: 22802416
   PubMed Web of Science ®Google Scholar
• Iikura M, Yamaguchi M, Fujisawa T, Miyamasu M, Takaishi T, Morita Y, Iwase T, Moro I, Yamamoto K, Hirai K. Secretory IgA induces degranulation of IL-3-primed basophils. J Immunol 1998; 161:1510 - 5; PMID: 9686618
   PubMed Web of Science ®Google Scholar
• Iikura M, Yamaguchi M, Miyamasu M, Morita Y, Iwase T, Moro I, Yamamoto K, Hirai K. Secretory IgA-mediated basophil activation. II. Roles of GTP-binding regulatory proteins and phosphatidylinositol 3-kinase. Biochem Biophys Res Commun 1999; 264:575 - 9; http://dx.doi.org/10.1006/bbrc.1999.1543; PMID: 10529404
   PubMed Web of Science ®Google Scholar
• Matsui T, Nunomura S, Shimokawa T, Yoshimaru T, Ra C. Functionality of the IgA Fc receptor (FcalphaR, CD89) is down-regulated by extensive engagement of FcepsilonRI. Clin Immunol 2008; 129:155 - 62; http://dx.doi.org/10.1016/j.clim.2008.07.003; PMID: 18700185
   PubMed Web of Science ®Google Scholar
• Milgrom H, Berger W, Nayak A, Gupta N, Pollard S, McAlary M, Taylor AF, Rohane P. Treatment of childhood asthma with anti-immunoglobulin E antibody (omalizumab). Pediatrics 2001; 108:E36; http://dx.doi.org/10.1542/peds.108.2.e36; PMID: 11483846
   PubMed Web of Science ®Google Scholar
• Pichler WJ. [Specific and nonspecific (anti-IgE) immunotherapy of allergic diseases]. Ther Umsch 2001; 58:329 - 36; http://dx.doi.org/10.1024/0040-5930.58.5.329; PMID: 11407237
   PubMedGoogle Scholar
• Peng Z. Vaccines targeting IgE in the treatment of asthma and allergy. Hum Vaccin 2009; 5:302 - 9; http://dx.doi.org/10.4161/hv.5.5.7442; PMID: 19221515
   PubMed Web of Science ®Google Scholar
• Pite H, Gaspar Â, Paiva M, Leiria-Pinto P. Omalizumab under 12 years old: real-life practice. Allergol Immunopathol (Madr) 2013; 41:133 - 6; http://dx.doi.org/10.1016/j.aller.2012.01.008; PMID: 22560014
   PubMed Web of Science ®Google Scholar
• Hambly N, Nair P. Monoclonal antibodies for the treatment of refractory asthma. Curr Opin Pulm Med 2014; 20:87 - 94; http://dx.doi.org/10.1097/MCP.0000000000000007; PMID: 24275927
   PubMed Web of Science ®Google Scholar
• Norman G, Faria R, Paton F, Llewellyn A, Fox D, Palmer S, Clifton I, Paton J, Woolacott N, McKenna C. Omalizumab for the treatment of severe persistent allergic asthma: a systematic review and economic evaluation. Health Technol Assess 2013; 17:1 - 342; PMID: 24267198
   PubMed Web of Science ®Google Scholar
• Babu KS, Polosa R, Morjaria JB. Anti-IgE--emerging opportunities for Omalizumab. Expert Opin Biol Ther 2013; 13:765 - 77; http://dx.doi.org/10.1517/14712598.2013.782391; PMID: 23517576
   PubMed Web of Science ®Google Scholar
• Gokmen NM, Ersoy R, Gulbahar O, Ardeniz O, Sin A, Unsel M, Kokuludag A. Desensitization effect of preseasonal seven-injection allergoid immunotherapy with olive pollen on basophil activation: the efficacy of olive pollen-specific preseasonal allergoid immunotherapy on basophils. Int Arch Allergy Immunol 2012; 159:75 - 82; http://dx.doi.org/10.1159/000335251; PMID: 22572984
   PubMed Web of Science ®Google Scholar
• Belliveau PP. Omalizumab: a monoclonal anti-IgE antibody. MedGenMed 2005; 7:27; PMID: 16369332
   PubMedGoogle Scholar
• Belliveau PP, Lahoz MR. Evaluation of omalizumab from a health plan perspective. J Manag Care Pharm 2005; b 11:735 - 45; PMID: 16300417
   PubMedGoogle Scholar
• Bang LM, Plosker GL. Spotlight on omalizumab in allergic asthma. BioDrugs 2004; 18:415 - 8; http://dx.doi.org/10.2165/00063030-200418060-00007; PMID: 15571425
   PubMed Web of Science ®Google Scholar
• Bang LM, Plosker GL. Omalizumab: a review of its use in the management of allergic asthma. Treat Respir Med 2004; 3:183 - 99; http://dx.doi.org/10.2165/00151829-200403030-00006; PMID: 15219177
   PubMedGoogle Scholar
• Buhl R, Marco AG, Cohen D, Canonica GW. Eligibility for treatment with omalizumab in Italy and Germany. Respir Med 2013; PMID: 24315468
   PubMed Web of Science ®Google Scholar
• Easthope S, Jarvis B. Omalizumab. Drugs 2001; 61:253 - 60, discussion 261; http://dx.doi.org/10.2165/00003495-200161020-00008; PMID: 11270941
   PubMed Web of Science ®Google Scholar
• Ridolo E, Montagni M, Melli V, Braido F, Incorvaia C, Canonica GW. Pharmacotherapy of allergic rhinitis: current options and future perspectives. Expert Opin Pharmacother 2014; 15:73 - 83; http://dx.doi.org/10.1517/14656566.2014.860445; PMID: 24219793
   PubMed Web of Science ®Google Scholar
• Kopp MV, Hamelmann E, Bendiks M, Zielen S, Kamin W, Bergmann KC, Klein C, Wahn U, DUAL study group. Transient impact of omalizumab in pollen allergic patients undergoing specific immunotherapy. Pediatr Allergy Immunol 2013; 24:427 - 33; http://dx.doi.org/10.1111/pai.12098; PMID: 23799935
   PubMed Web of Science ®Google Scholar
• Aryan Z, Compalati E, Canonica GW, Rezaei N. Allergen-specific immunotherapy in asthmatic children: from the basis to clinical applications. Expert Rev Vaccines 2013; 12:639 - 59; http://dx.doi.org/10.1586/erv.13.45; PMID: 23750794
   PubMed Web of Science ®Google Scholar
• Burch J, Griffin S, McKenna C, Walker S, Paton J, Wright K, Woolacott N. Omalizumab for the treatment of severe persistent allergic asthma in children aged 6-11 years: a NICE single technology appraisal. Pharmacoeconomics 2012; 30:991 - 1004; http://dx.doi.org/10.2165/11597160-000000000-00000; PMID: 22950547
   PubMed Web of Science ®Google Scholar
• Lieberman JA, Chehade M. Use of omalizumab in the treatment of food allergy and anaphylaxis. Curr Allergy Asthma Rep 2013; 13:78 - 84; http://dx.doi.org/10.1007/s11882-012-0316-x; PMID: 23065311
   PubMed Web of Science ®Google Scholar
• Rodríguez-Trabado A, Fernández Pereira LM, Romero-Chala S, García-Trujillo JA, Cámara Hijón C. Monitoring omalizumab treatment efficacy in chronic urticaria by the basophil activation test. Allergol Immunopathol (Madr) 2012; 40:390 - 2; http://dx.doi.org/10.1016/j.aller.2011.09.009; PMID: 22178123
   PubMed Web of Science ®Google Scholar
• Jandus P, Hausmann O, Haeberli G, Gentinetta T, Mueller U, Helbling A. Unpredicted adverse reaction to omalizumab. J Investig Allergol Clin Immunol 2011; 21:563 - 6; PMID: 22312942
   PubMed Web of Science ®Google Scholar
• Vousden KA, Clarke DL, Lowe DC. Engineering approaches to develop the next generation of antibodies to respiratory targets. Inflamm Allergy Drug Targets 2013; 12:99 - 108; http://dx.doi.org/10.2174/1871528111312020004; PMID: 23517646
   PubMedGoogle Scholar
• O’Byrne PM. Role of monoclonal antibodies in the treatment of asthma. Can Respir J 2013; 20:23 - 5; PMID: 23457670
   PubMed Web of Science ®Google Scholar
• Mortensen DL, Prabhu S, Stefanich EG, Kadkhodayan-Fischer S, Gelzleichter TR, Baker D, Jiang J, Wallace K, Iyer S, Fielder PJ, et al. Effect of antigen binding affinity and effector function on the pharmacokinetics and pharmacodynamics of anti-IgE monoclonal antibodies. MAbs 2012; 4:724 - 31; http://dx.doi.org/10.4161/mabs.22216; PMID: 23778267
   PubMed Web of Science ®Google Scholar
• Khan FM, Ueno-Yamanouchi A, Serushago B, Bowen T, Lyon AW, Lu C, Storek J. Basophil activation test compared to skin prick test and fluorescence enzyme immunoassay for aeroallergen-specific Immunoglobulin-E. Allergy Asthma Clin Immunol 2012; 8:1; http://dx.doi.org/10.1186/1710-1492-8-1; PMID: 22264407
   PubMed Web of Science ®Google Scholar
• Park HJ, Kim HS, Chung DH. Fcgamma receptors modulate pulmonary inflammation by activating innate immune cells in murine hypersensitivity pneumonitis. Immune Netw 2010; 10:26 - 34; http://dx.doi.org/10.4110/in.2010.10.1.26; PMID: 20228933
   PubMedGoogle Scholar
• Vercelli D, De Monte L, Monticelli S, Di Bartolo C, Agresti A. To E or not to E? Can an IL-4-induced B cell choose between IgE and IgG4?. Int Arch Allergy Immunol 1998; 116:1 - 4; http://dx.doi.org/10.1159/000023918; PMID: 9623503
   PubMed Web of Science ®Google Scholar
• Vashisht P, Casale T. Omalizumab for treatment of allergic rhinitis. Expert Opin Biol Ther 2013; 13:933 - 45; http://dx.doi.org/10.1517/14712598.2013.795943; PMID: 23621175
   PubMed Web of Science ®Google Scholar
• Maurer M, Rosén K, Hsieh HJ, Saini S, Grattan C, Gimenéz-Arnau A, Agarwal S, Doyle R, Canvin J, Kaplan A, et al. Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria. N Engl J Med 2013; 368:924 - 35; http://dx.doi.org/10.1056/NEJMoa1215372; PMID: 23432142
   PubMed Web of Science ®Google Scholar
• Bruhns P, Frémont S, Daëron M. Regulation of allergy by Fc receptors. Curr Opin Immunol 2005; 17:662 - 9; http://dx.doi.org/10.1016/j.coi.2005.09.012; PMID: 16214316
   PubMed Web of Science ®Google Scholar
• Siegmund R, Vogelsang H, Machnik A, Herrmann D. Surface membrane antigen alteration on blood basophils in patients with Hymenoptera venom allergy under immunotherapy. J Allergy Clin Immunol 2000; 106:1190 - 5; http://dx.doi.org/10.1067/mai.2000.110928; PMID: 11112905
   PubMed Web of Science ®Google Scholar
• Wood RA, Sicherer SH, Burks AW, Grishin A, Henning AK, Lindblad R, Stablein D, Sampson HA. A phase 1 study of heat/phenol-killed, E. coli-encapsulated, recombinant modified peanut proteins Ara h 1, Ara h 2, and Ara h 3 (EMP-123) for the treatment of peanut allergy. Allergy 2013; 68:803 - 8; http://dx.doi.org/10.1111/all.12158; PMID: 23621498
   PubMed Web of Science ®Google Scholar
• Chirumbolo S, Vella A, Ortolani R, De Gironcoli M, Solero P, Tridente G, Bellavite P. Differential response of human basophil activation markers: a multi-parameter flow cytometry approach. Clin Mol Allergy 2008; 6:12; http://dx.doi.org/10.1186/1476-7961-6-12; PMID: 18925959
   PubMedGoogle Scholar
• Chirumbolo S, Ortolani R, Vella A. CCR3 as a single selection marker compared to CD123/HLADR to isolate basophils in flow cytometry: some comments. Cytometry A 2011; 79:102 - 6; http://dx.doi.org/10.1002/cyto.a.21008; PMID: 21265004
   PubMed Web of Science ®Google Scholar
• Sainte-Laudy J, Boumediene A, Touraine F, Orsel I, Brianchon C, Bonnaud F, Cogné M. Use of both CD63 up regulation and IgE down regulation for the flow cytometric analysis of allergen induced basophil activation. Definition of an activation index. Inflamm Res 2007; 56:291 - 6; http://dx.doi.org/10.1007/s00011-007-7014-5; PMID: 17659434
   PubMed Web of Science ®Google Scholar
• Özdemir SK, Güloğlu D, Sin BA, Elhan AH, Ikincioğulları A, Mısırlıgil Z. Reliability of basophil activation test using CD203c expression in diagnosis of pollen allergy. Am J Rhinol Allergy 2011; 25:e225 - 31; http://dx.doi.org/10.2500/ajra.2011.25.3723; PMID: 22185730
   PubMedGoogle Scholar
• De Week AL, Sanz ML, Gamboa PM, Aberer W, Bienvenu J, Blanca M, Demoly P, Ebo DG, Mayorga L, Monneret G, et al. Diagnostic tests based on human basophils: more potentials and perspectives than pitfalls. II. Technical issues. J Investig Allergol Clin Immunol 2008; 18:143 - 55; PMID: 18564624
   PubMed Web of Science ®Google Scholar
• Chirumbolo S. CD164 and other recently discovered activation markers as promising tools for allergy diagnosis: what’s new?. Clin Exp Med 2011; 11:255 - 7; http://dx.doi.org/10.1007/s10238-011-0132-y; PMID: 21461759
   PubMed Web of Science ®Google Scholar
• Subbarayal B, Schiller D, Möbs C, de Jong NW, Ebner C, Reider N, Bartel D, Lidholm J, Pfützner W, Gerth van Wijk R, et al. Kinetics, cross-reactivity, and specificity of Bet v 1-specific IgG4 antibodies induced by immunotherapy with birch pollen. Allergy 2013; 68:1377 - 86; http://dx.doi.org/10.1111/all.12236; PMID: 24053565
   PubMed Web of Science ®Google Scholar
• Sturm EM, Kranzelbinder B, Heinemann A, Groselj-Strele A, Aberer W, Sturm GJ. CD203c-based basophil activation test in allergy diagnosis: characteristics and differences to CD63 upregulation. Cytometry B Clin Cytom 2010; 78:308 - 18; http://dx.doi.org/10.1002/cyto.b.20526; PMID: 20533392
   PubMed Web of Science ®Google Scholar
• Nullens S, Sabato V, Faber M, Leysen J, Bridts CH, De Clerck LS, Falcone FH, Maurer M, Ebo DG. Basophilic histamine content and release during venom immunotherapy: insights by flow cytometry. Cytometry B Clin Cytom 2013; 84:173 - 8; http://dx.doi.org/10.1002/cyto.b.21084; PMID: 23450838
   PubMed Web of Science ®Google Scholar
• Gadermaier E, Flicker S, Blatt K, Valent P, Valenta R. Possible therapeutic potential of a recombinant group 2 grass pollen allergen-specific antibody fragment. Allergy 2013; Forthcoming PMID: 24251384
   PubMed Web of Science ®Google Scholar
• Pellaton C, Perrin Y, Boudousquié C, Barbier N, Wassenberg J, Corradin G, Thierry AC, Audran R, Reymond C, Spertini F. Novel birch pollen specific immunotherapy formulation based on contiguous overlapping peptides. Clin Transl Allergy 2013; 3:17; http://dx.doi.org/10.1186/2045-7022-3-17; PMID: 23725004
   PubMedGoogle Scholar
• Prickett SR, Voskamp AL, Phan T, Dacumos-Hill A, Mannering SI, Rolland JM, O’Hehir RE. Ara h 1 CD4+ T cell epitope-based peptides: candidates for a peanut allergy therapeutic. Clin Exp Allergy 2013; 43:684 - 97; PMID: 23711131
   PubMed Web of Science ®Google Scholar
• Grützkau A, Smorodchenko A, Lippert U, Kirchhof L, Artuc M, Henz BM. LAMP-1 and LAMP-2, but not LAMP-3, are reliable markers for activation-induced secretion of human mast cells. Cytometry A 2004; 61:62 - 8; http://dx.doi.org/10.1002/cyto.a.20068; PMID: 15351990
   PubMed Web of Science ®Google Scholar
• Knol EF, Mul FP, Jansen H, Calafat J, Roos D. Monitoring human basophil activation via CD63 monoclonal antibody 435. J Allergy Clin Immunol 1991; 88:328 - 38; http://dx.doi.org/10.1016/0091-6749(91)90094-5; PMID: 1716273
   PubMed Web of Science ®Google Scholar
• Gyimesi E, Gönczi F, Szilasi M, Pál G, Baráth S, Sipka S. The effects of various doses of bacterial lipopolysaccharide on the expression of CD63 and the release of histamine by basophils of atopic and non-atopic patients. Inflamm Res 2013; 62:213 - 8; http://dx.doi.org/10.1007/s00011-012-0569-9; PMID: 23109053
   PubMed Web of Science ®Google Scholar
• Boumiza R, Debard AL, Monneret G. The basophil activation test by flow cytometry: recent developments in clinical studies, standardization and emerging perspectives. Clin Mol Allergy 2005; 3:9; http://dx.doi.org/10.1186/1476-7961-3-9; PMID: 15989690
   PubMedGoogle Scholar
• Eberlein B, León Suárez I, Darsow U, Ruëff F, Behrendt H, Ring J. A new basophil activation test using CD63 and CCR3 in allergy to antibiotics. Clin Exp Allergy 2010; 40:411 - 8; http://dx.doi.org/10.1111/j.1365-2222.2009.03426.x; PMID: 20082620
   PubMed Web of Science ®Google Scholar
• Wolanczyk-Medrala A, Barg W, Liebhart J, Panaszek B, Nadobna G, Litwa M, Gogolewski G, Medrala W. Validation of basophil CD164 upregulation for pollen allergy diagnosis. Arch Immunol Ther Exp (Warsz) 2010; 58:459 - 65; http://dx.doi.org/10.1007/s00005-010-0104-z; PMID: 20872290
   PubMed Web of Science ®Google Scholar
• Thyagarajan A, Jones SM, Calatroni A, Pons L, Kulis M, Woo CS, Kamalakannan M, Vickery BP, Scurlock AM, Wesley Burks A, et al. Evidence of pathway-specific basophil anergy induced by peanut oral immunotherapy in peanut-allergic children. Clin Exp Allergy 2012; 42:1197 - 205; http://dx.doi.org/10.1111/j.1365-2222.2012.04028.x; PMID: 22805467
   PubMed Web of Science ®Google Scholar
• Ford LS, Bloom KA, Nowak-Węgrzyn AH, Shreffler WG, Masilamani M, Sampson HA. Basophil reactivity, wheal size, and immunoglobulin levels distinguish degrees of cow’s milk tolerance. J Allergy Clin Immunol 2013; 131:180 - , e1-3; http://dx.doi.org/10.1016/j.jaci.2012.06.003; PMID: 22819512
   PubMed Web of Science ®Google Scholar
• Wanich N, Nowak-Wegrzyn A, Sampson HA, Shreffler WG. Allergen-specific basophil suppression associated with clinical tolerance in patients with milk allergy. J Allergy Clin Immunol 2009; 123:789 - , e20; http://dx.doi.org/10.1016/j.jaci.2008.12.1128; PMID: 19348919
   PubMed Web of Science ®Google Scholar